Feb 1 |
ABEO: FDA BIMO Inspection and BLA Mid-Cycle Review Complete…
|
Feb 1 |
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
|
Jan 16 |
Abeona Therapeutics Inc. (NASDAQ:ABEO): When Will It Breakeven?
|
Jan 8 |
Abeona Therapeutics announces $50M credit facility
|
Jan 8 |
Abeona Therapeutics Announces $50 Million Credit Facility
|
Dec 23 |
Those who invested in Abeona Therapeutics (NASDAQ:ABEO) a year ago are up 98%
|
Nov 29 |
ABEO: BLA for Pz-Cel (EB-101) Accepted with Priority Review; PDUFA Date of May 25, 2024…
|
Nov 27 |
Abeona shares jump after FDA priority review for epidermolysis bullosa drug
|
Nov 27 |
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
|
Nov 17 |
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2023 Earnings Call Transcript
|